Xcout Intel
Exciva competitors & alternatives
The 12 closest competitors and alternatives to Exciva among life sciences companies — ranked by similarity to what Exciva actually does, not by market-cap band.
Subscribe to see Exciva’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Exciva
EXCIVA GmbH is a privately held biotechnology company established in 2016 in Heidelberg, Germany, focused on developing clinical-stage therapeutics to improve quality of life and treat Alzheimer's disease.
Exciva at a glance
Exciva is a life sciences company headquartered in Germany. Its most recent funding round, Series B, raised $59M in January 2026. Xcout tracks 16 named people at Exciva, including François Conquet (CEO).
Exciva leadership
- François ConquetCEO
- Nadine KnowlesCOO
- Francisco OrellanaCFO
- Anton BespalovCo-founder, CSO and Managing Director
- Hans J. MoebiusCo-founder and CMO
- Sreenivasarao VepacheduCo-founder and Patent Attorney
10 more named people on record for Exciva, with roles, board committees and tenure — see the full roster →
Exciva funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $59M | 10 named | |
| — | $10.4M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Exciva competitors
Ranked by semantic similarity — how close each company is to Exciva by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Ultimate Medicine AG is a Swiss preclinical biotechnology company headquartered in Zürich, focused on maximizing the healthspan of patients with Alzheimer's disease and other dementias by targeting novel toxic metabolites.
Biotech
Alzinova AB is a Swedish clinical-stage biopharmaceutical company that develops disease-modifying treatments and vaccines targeting Alzheimer's disease. Utilizing its proprietary AβCC Peptide technology, the company focuses on creating therapeutics for Alzheimer's patients to address high unmet medical needs in neurodegeneration.
Biotechnology
Asceneuron is a biotechnology research company founded in 2012 and headquartered in Eysins, Switzerland, focusing on the discovery and development of therapeutics for neurodegenerative disorders.
Biotechnology
Muna Therapeutics is a privately held biopharmaceutical company founded in 2020 with headquarters in Copenhagen, Denmark, and operations in Leuven. The company discovers and develops novel therapies aimed at slowing or stopping devastating neurodegenerative diseases like Alzheimer's and Parkinson's.
Biotechnology
Probiodrug AG is a biopharmaceutical company headquartered in Halle, Germany, that aims to become a leading enterprise in its field and has previously held an initial public offering on Euronext Amsterdam. The company's focus includes addressing conditions such as Alzheimer's disease through specialized therapeutic development.
Biotechnology
Recognify Life Sciences is a clinical-stage biotechnology company located in California, focusing on developing treatments for cognitive impairment associated with central nervous system disorders.
Biotech
NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.
Biotechnology
Revier Therapeutics is a biotechnology company headquartered in Heidelberg, Germany, founded in 2023. The company closed a EUR 6 million seed financing round to advance its therapeutic pipeline and research operations.
Similar life sciences company
Cortexyme, Inc. is a biopharmaceutical company headquartered in South San Francisco, California, focused on discovering and developing therapeutics for major degenerative disorders.
Biotechnology
AstronauTx is a clinical-stage biotechnology company headquartered in London, United Kingdom. Founded in 2019, the firm develops novel small-molecule drugs aimed at treating neurodegenerative conditions such as Alzheimer's disease by targeting glial cell dysfunction.
Biotechnology
Evecxia, Inc. is a holding and therapeutics company founded in 2013 and based in North Carolina, focusing on drug pipelines, patents, and clinical trials for neuropsychiatric conditions.
Biotechnology
Amygdala Neurosciences Inc is an independent small biopharmaceutical company headquartered in San Francisco, California. Its mission is to invent and develop first-in-class therapeutics.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Exciva and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Excivaand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →